Rnz: Morning Report
MS sufferers in Canterbury missing out on new drug
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:03:55
- Mas informaciones
Informações:
Sinopsis
Dozens of multiple sclerosis sufferers in Canterbury are not getting access to an approved new drug Ocrelizumab. Local businessman Bruce Street spoke to Ingrid Hipkiss.
